Home › Squamous Cell Carcinoma ng Ulo at Leeg › Ohio › Cincinnati
Pag-aaral pangklinika para sa Squamous Cell Carcinoma ng Ulo at Leeg sa Cincinnati, OH
14 pag-aaral para sa Squamous Cell Carcinoma ng Ulo at Leeg ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Cincinnati (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Nagre-recruitPhase 2/3
- Site#0117, Cincinnati
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Nagre-recruitPhase 3
- University of Cincinnati, Cincinnati
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Nagre-recruitPhase 3
- University of Cincinnati, Cincinnati
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
Nagre-recruitPhase 2
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi ang layo
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Nagre-recruitPhase 2
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- at 4 pa
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Nagre-recruitObservasyonal na pag-aaral
- University of Cincinnati, Cincinnati
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Nagre-recruitPhase 2
- St. Elizabeth Healthcare, Edgewood · 8 mi ang layo
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Nagre-recruitPhase 2
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi ang layo
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
Nagre-recruitPhase 3
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi ang layo
Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma
Nagre-recruitPhase 1/2
- University of Cincinnati Medical Center, Cincinnati
Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma
Nagre-recruitPhase 2
- University of Cincinnati Medical Center, Cincinnati
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Carl & Edyth Lindner Center for Research & Education at The Christ Hospital and The Christ Hospital Cancer Center, Cincinnati
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Research Site 113, Cincinnati
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
Nagre-recruitPhase 1/2
- The Christ Hospital, Cincinnati
Pag-aaral para sa Squamous Cell Carcinoma ng Ulo at Leeg sa ibang lungsod
- Houston, TX47 pag-aaral
- Los Angeles, CA42 pag-aaral
- Boston, MA40 pag-aaral
- Nashville, TN39 pag-aaral
- New York City, NY39 pag-aaral
- St. Louis, MO28 pag-aaral
- Arlington, VA26 pag-aaral
- Chicago, IL26 pag-aaral
- Philadelphia, PA26 pag-aaral
- Atlanta, GA24 pag-aaral
- Pittsburgh, PA22 pag-aaral
- New Haven, CT22 pag-aaral
Iba pang pag-aaral sa Cincinnati
- Non-Small Cell Lung Cancer35 pag-aaral
- Kanser (lahat ng uri)27 pag-aaral
- Kanser sa Suso25 pag-aaral
- Pagkabigo ng Puso24 pag-aaral
- Colorectal Cancer21 pag-aaral
- Acute Myeloid Leukemia20 pag-aaral
- Metastatic Cancer20 pag-aaral
- Kanser sa Ovary19 pag-aaral
- Kanser sa Baga19 pag-aaral
- Obesity19 pag-aaral
- Kanser sa Prostate18 pag-aaral
- Multiple Myeloma17 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.